Notably, we identified TREX1 overexpression not only in chemoresistant SCLC cell lines but also in human SCLC tumors, confirmed by comparing TREX1 protein expression in pre- and post-chemotherapy paired-clinical samples. This evidence concerns the gene TREX1 and small cell lung carcinoma.